Browse All

Current Filters

CLEAR FILTER x

TITLE

Characterizing Disability and MRI Outcomes in Latinx People with Multiple Sclerosis Before and After the COVID-19 Pandemic

Author:Hersh, Carrie   Du, Mengke   Worley, Sarah   Ontaneda, Daniel   Briggs, Farren   Conway, Devon   

Session Name:P4: Multiple Sclerosis: Outcomes Research and Health Care Disparities  

Topic:Multiple Sclerosis  

Program Number:P4.006  

Author Institution:Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV  Cleveland Clinic Department of Biostatistics, Cleveland, OH  Cleveland Clinic Mellen Center for MS Treatment and Research, Cleveland, OH  University of Miami Miller School of Medicine, Miami, FL  

ENABLE: The First Phase 4 Observational Study for Patients with Relapsing MS Treated with Ublituximab in Real World Clinical Setting

Author:Fox, Edward   Parker, Jackie   Bodhinathan, Karthik   Sportelli, Peter   Miskin, Hari   Hersh, Carrie   

Session Name:P7: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 1  

Topic:Multiple Sclerosis  

Program Number:P7.014  

Author Institution:TG Therapeutics, Round Rock, TX  TG Therapeutics, Morrisville, NC  TG Therapeutics, Lexington, MA  TG Therapeutics, New York, NY  Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV  

Matching-adjusted Indirect Comparisons of Diroximel Fumarate, Ocrelizumab, and Interferon Beta-1a

Author:Hersh, Carrie   Aladro, Yolanda   Lewin, James   Shen, Changyu   Bozin, Ivan   Sun, Zhaonan   

Session Name:P11: Multiple Sclerosis: Clinical and Translational Research in MS 1  

Topic:Multiple Sclerosis  

Program Number:P11.005  

Author Institution:Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV  Hospital Universitario de Getafe, Madrid, Spain  Biogen, Cambridge, MA  Biogen, Baar, Switzerland